BU-NOT-SET

CONTACT US
A new centre for continuous mRNA manufacturing
  • Biologics
mRNA manufacture
Insight
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
White paper
  • Drug product
  • Manufacturing
Safely scaling high potency API manufacturing
Insight
  • Drug product
  • Manufacturing
From development insight to manufacturing confidence
Insight
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing RNA Therapeutics
Insight
  • Drug product
  • Industry trends
Advancing high potency manufacturing through enhanced containment and sustainable process design
Insight
  • Drug product
  • Industry trends
2025 Industry trends and 2026 predictions
Insight
  • Drug product
The value of granulation in modern solid dose development
Insight
  • Biologics
  • Manufacturing
Lyophilisation: Key to overcoming stability hurdles for complex therapeutics
Insight
  • Drug product
  • Manufacturing
Key trends shaping high-potency API manufacturing in 2026
Webinar
  • Drug product
  • Manufacturing
Webinar | High potent API manufacturing: Strategies, safety & scale-up